# Monitoring Anti-Dementia Drugs by Serum Levels

> **NCT04117178** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 132 (actual)

## Conditions studied

- Dementia
- Dementia With Lewy Bodies
- Dementia in Parkinsons Disease
- Dementia Alzheimers
- Alzheimer Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Memantine
- **DIAGNOSTIC_TEST:** Measurement of serum level of anti-dementia drug

## Key facts

- **NCT ID:** NCT04117178
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-04
- **Primary completion:** 2023-02-16
- **Final completion:** 2023-02-16
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117178, "Monitoring Anti-Dementia Drugs by Serum Levels". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04117178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*